Joinpoint Regression Analysis of Potential Years of Life Lost Due to Main Causes of Death in Poland, Years 2002–2011

• Authors: Michalina Krzyżak , Dominik Maślach , Martyna Skrodzka , Katarzyna Florczyk , Anna Szpak , Bartosz Pędziński , Paweł Sowa , Andrzej Szpak
• Languages of publication: EN

Abstracts

EN

The purpose of the study was to analyse the level and the trends of Potential Years of Life Lost due to the main causes of death in Poland in the years 2002-2011. The material for the study was the information from the Central Statistical Office on the number of deaths due to the main causes of death in Poland in the years 2002-2011. The premature mortality analysis was conducted with the use of the PYLL (Potential Years of Life Lost) indicator. PYLL rate was calculated following the method proposed by J. Romeder, according to which premature mortality was defined as death before the age of 70. Time trends of PYLL rate and the average annual percent change (APC - Annual Percent Change) were assessed using jointpoint models and the Joinpoint Regression Program. In the years 2002-2011, PYLL rate for all-cause deaths decreased by 7.0% among men and 8.1% among women. In 2011, the main reasons for PYLL among men were: external causes (27.6%), cardiovascular diseases (24.2%) and cancers (20.3%). Among women the leading causes were: cancers (41.1%), cardiovascular diseases (19.7%) and external causes (12.5%). PYLL rate increased among men for colorectal cancer, and among women for colorectal and lung cancer. The presented epidemiological situation for premature mortality in Poland shows that in the majority of cases it is caused by preventable deaths, which highlights a need to intensify measures in primary and secondary prevention.

• Publisher: Sciendo
• Journal: Studies in Logic, Grammar and Rhetoric
• Year: 2013
• Volume: 35
• Issue: 1
• Pages: 157-167

Dates

published

2013-12-01

online

2013-12-31

Contributors

author

Michalina Krzyżak

• Department of Public Health, Medical University of Bialystok, Poland

author

Dominik Maślach

• Department of Public Health, Medical University of Bialystok, Poland

author

Martyna Skrodzka

• Students Scientific Group of Public Health, Department of Public Health, Medical University of Bialystok, Poland

author

Katarzyna Florczyk

• Students Scientific Group of Public Health, Department of Public Health, Medical University of Bialystok, Poland

author

Anna Szpak

• Department of Restorative Dentistry, Medical University of Bialystok, Poland

author

Bartosz Pędziński

• Department of Public Health, Medical University of Bialystok, Poland

author

Paweł Sowa

• Department of Public Health, Medical University of Bialystok, Poland

author

Andrzej Szpak

• Department of Public Health, Medical University of Bialystok, Poland

References

• Arbyn, M., Raifu, A. O., Weiderpass, E., Bray, F., & Anttila, A. (2009). Trends of cervical cancer mortality in the member states. Eur J Cancer, 45(15), 2640-2648.[Crossref][PubMed]
• Bosetti, C., Levi, F., Rosato, V., Bertuccio, P., Lucchini, F., Negri, E., & La Vecchia, C. (2011). Recent trends in colorectal cancer mortality in Europe. Int J Cancer, 129(1), 180-191.
• Bosetti, C., Malvezzi, M., Rosso, T., Bertuccio, P., Gallus, S., Chatenoud, L., Levi, F., Negri, E., & La Vecchia, C. (2012). Lung cancer mortality in European women: trends and predictions. Lung Cancer, 78, 171-178.[WoS]
• Colin, M., Thies, B., & Doris, M. F. (2004). Global burden of Disease: update 2004. World Health Organisation.
• Didkowska, J., Wojciechowska, U., & Zatoński, W. (2011). Nowotwory złośliwe w Polsce w 2009 roku. Warszawa: Centrum Onkologii, Instytut im. M. Skłodowskiej-Curie.
• European Commission. (2010). Health trends in the UE.
• Gardner, J., & Sanborn, J. (1990). Years of potential life lost (YPLL) - what does it measure? Epidemiology, 1(4), 322-329.
• Gatta, G., Zigon, G., Aareleid, T., Ardanaz, E., Bielska-Lasota, M., Galceran, J., Goźdź, S., Hakulinen, T., Martinez-Garcia, C., Plesko, I., Zakelj, M. P., Rachtan, J., Tagliabue, G., Vercelli, M., & Faivre, J. (2010). Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE High Resolution Study. Acta Oncol., 49(6), 776-783.[WoS]
• Gromulska, L., Wysocki, M. J., & Goryński, P. (2008). Lata przeżyte w zdrowiu (Healthy Life Years, HYL) - zalecany przez Unię Europejską syntetyczny wskaźnik sytuacji zdrowotnej ludności. Przegl Epidemiol, 62, 811-820.
• Kim, H. J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000). Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 19(3), 335-351. (correction: 2001; 20: 655) [PubMed][Crossref]
• National Cancer Institute, Statistical Research and Applications Branch. (2013). Joinpoint Regression Program (Version 4.0.4.).
• OECD (2007). Health at a Glance 2007: OECD Indicators. OECD Publishing. DOI: 10.1787/health glance-2007-en.[Crossref]
• OECD (2011). Health at a Glance 2011: OECD Indicators. OECD Publishing. DOI: 10.1787/health glance-2011-en.[Crossref]
• Romeder, J., & McWhinnie, J. (1977). Potential Years of Life Lost Between Ages 1 and 70: An Indicator of Premature Mortality for Health Planning. Int J Epidemiol, 6(2), 143-151.[PubMed][Crossref]
• Savidan, A., Junker, Ch., Cerny, T., & Ess, S. (2010). Premature mortality in Switzerland from 1995-2006: causes and trends. Swiss Med Wkly., 140:w13077. DOI: 10.4414/smw.2010.13077.[Crossref][WoS]
• Tyczyński, J. E., Bray, F., Aareleid, T., Dalmas, M., Kurtinaitis, J., Plesko, I., Pompe-Kirn, V., Stengrevics, A., & Parkin, D. M. (2004). Lung cancer mortality patterns in selected Central, Eastern and Southern European countries. Int J Cancer, 109(4), 598-610.
• Wojtyniak, B., Goryński, P., & Moskalewicz, B. (2012). Sytuacja zdrowotna ludności Polski i jej uwarunkowania (pp. 58-59). Warszawa: Narodowy Instytut Zdrowia Publicznego.
• World Health Organization. (2004). International Statistical Classification of Diseases and Health Related Problems: tenth revision (2nd ed.). Geneva: WHO.
• Zatoński, W. (1996). Evaluation of health in Poland since 1988. Warszawa: Centrum Onkologii, Instytut im. M. Skłodowskiej-Curie.

Identifiers

DOI

10.2478/slgr-2013-0042